Spliceosomopathies: Diseases and mechanisms

Area of Science:

• Molecular Biology
• Genetics
• Cell Biology

Background:

• The spliceosome, a complex of RNA and proteins, is crucial for precursor messenger RNA (pre-mRNA) splicing.
• Mutations in spliceosome components can lead to a class of diseases known as spliceosomopathies.
• While spliceosomes are ubiquitous, spliceosomopathies exhibit tissue-specific phenotypes, affecting organs like the retina, hematopoietic system, and craniofacial skeleton.

Purpose of the Study:

• To describe major spliceosomopathies.
• To review proposed mechanisms for retinitis pigmentosa and myelodysplastic syndromes.
• To explore how understanding these mechanisms can inform the study of craniofacial spliceosomopathies.

Main Methods:

• Literature review of spliceosomopathies.
• Analysis of proposed pathomechanisms in retinitis pigmentosa and myelodysplastic syndromes.
• Comparative discussion of spliceosomopathy phenotypes and genetic underpinnings.

Main Results:

• Spliceosomopathies are linked to mutations in genes encoding spliceosome proteins.
• Tissue specificity of spliceosomopathies arises from germline or somatic mutations.
• Retinitis pigmentosa, myelodysplastic syndromes, and mandibulofacial dysostosis are examples of spliceosomopathies.

Conclusions:

• Spliceosome dysfunction is a significant cause of human genetic disorders.
• Understanding the molecular basis of spliceosomopathies is essential for disease diagnosis and treatment.
• Further research into craniofacial spliceosomopathies may benefit from insights gained from studying other affected tissues.